Pharsight

BRISTOL MYERS SQUIBB CO patents facing oppositions

Top patents of BRISTOL MYERS SQUIBB CO facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3322731B1 13 Jan, 2021 Method of treating cancer using immune checkpoint inhibitor; antibody that binds to programmed death-1 receptor (pd-1) or programmed death ligand 1 (pd-l1) Jul, 2036 10
EP3464373B1 27 Oct, 2021 Use of anti-pd-1 antibody in the treatment of patients with colorectal cancer Jun, 2037 6
EP3288980B1 10 Mar, 2021 Treatment of pd-l1-positive melanoma using an anti-pd-1 antibody Apr, 2036 5